Flash glucose monitoring was reported to provide $474 AUD ($333 USD) cost savings over 1 year compared to SMBG and heterogeneous insulin delivery methods in the UK [28], based on the ‘Novel Glucose-Sensing Technology and Hypoglycemia in Type 1 Diabetes: a Multicentre, Non-masked, Randomised Controlled Trial’ (IMPACT study) [29]. The gene discussed is INS; the disease is type 1 diabetes mellitus.